Down-regulation of CTGF suppresses proliferation, migration, and invasion of bladder cancer cells in vitro and targeting of CTGF decelerated xenograft growth in vivo (Wang X. et al., 2017). The gene discussed is CCN2; the disease is urinary bladder carcinoma.